Back
Tekla Healthcare Opportunities Fund Vs. Summit Therapeutics Industry Stock Comparison
Sell
25
THQ
Tekla Healthcare Opportunities Fund
Last Price:
21.93
Seasonality Move:
-1.36%
Buy
79
SMMT
Summit Therapeutics
Last Price:
24.55
Seasonality Move:
26.72%
Sell
25
Tekla Healthcare Opportunities Fund (THQ)
is a Sell
Is Tekla Healthcare Opportunities Fund a Buy, Sell or Hold?
- The current Tekla Healthcare Opportunities Fund [THQ] share price is $21.86. The Score for THQ is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- THQ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
79
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $26.22. The Score for SMMT is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
THQ Stock Price Chart
What is Tekla Healthcare Opportunities Fund's stock price today?
-
The Tekla Healthcare Opportunities Fund share price today is $21.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and THQ is experiencing slight selling pressure.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $26.22
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
THQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 57.94 | Buy |
| Chaikin Money Flow: | -29704 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.33 - 21.81) | Buy |
| Bollinger Bands (100): | (20.05 - 21.49) | Buy |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.4 | Buy |
| Relative Strength Index (14 RSI): | 69.61 | Buy |
| Chaikin Money Flow: | -7453022 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.89 - 22.53) | Buy |
| Bollinger Bands (100): | (4.23 - 14.99) | Buy |
THQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.73 | Buy |
| 20-day SMA: | 21.66 | Buy |
| 50-day SMA: | 21.4 | Buy |
| 200-day SMA: | 19.86 | Buy |
| 8-day EMA: | 21.77 | Buy |
| 20-day EMA: | 21.64 | Buy |
| 50-day EMA: | 21.32 | Buy |
| 200-day EMA: | 20.14 | Buy |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.01 | Buy |
| 20-day SMA: | 17.36 | Buy |
| 50-day SMA: | 13.03 | Buy |
| 200-day SMA: | 6.61 | Buy |
| 8-day EMA: | 24.48 | Buy |
| 20-day EMA: | 19.28 | Buy |
| 50-day EMA: | 14.43 | Buy |
| 200-day EMA: | 8.04 | Buy |
Tekla Healthcare Opportunities Fund Earnings Growth & THQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Tekla Healthcare Opportunities Fund Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||